Dr. Satoshi Kashiwagi, a Principal Investigator at VIC, receives 2016 DOM Innovation Pilot Grant. This award is created by the Medicine Innovation Program to accelerate the development and introduction of innovative ideas that clearly move an existing project along a defined path from idea to working solution. In this project entitled “Near-infrared laser to augment antigen specific tolerance”, Dr. Kashiwagi hopes to successfully develop an effective immunotherapy using laser light that will save patients suffering from autoimmune diseases.
Dr. Kashiwagi is Assistant Professor of Medicine at Harvard Medical School. He was trained as an obstetrician in Japan, and finished his research training at MGH in the fields of tumor angiogenesis and nitric oxide biology. He is currently running his laboratory in VIC with support of NIH R01 grant. His laboratory’s central focus has been to develop a new class of energy-based, physical immunological adjuvants.